Senegal Introduces The Inactivated Polio Vaccine (IPV)

Senegal
30 January 2015

Senegal, declared free from the circulation of the indigenous wild Polio virus since 2004, has endorsed the SAGE recommendation and has programmed, with the support of its partners, the introduction of the inactivated polio vaccine (IPV) in its Expanded Program on Immunization (EPI) in January 2015.
This decision was also based at the national level on the recommendation received from the Advisory Committee for Vaccination in Senegal (CCVS).                                                                                                              

A launching ceremony occured in Dakar on the 30th of January 2015.

Related News & Events

  • Senegal

    Six steps for successfully proposing a recommendation

    04.04.2017

    In Senegal, the NITAG (CCVS) Chair tasks six experts to work on cerebrospinal meningitis. The objective is simple: to define whether or not it is appropriate to introduce the MenAfriVac in the routine EPI, starting from 2017. Indeed, Senegal is inside a meningitis belt and is regularly exposed to epidemic flares of cerebrospinal meningitis (CSM).
    The vaccine was introduced in the country as part of a campaign in 2012. WHO recommends that the vaccine be introduced into the routine EPI within five years of a campaign. Then, in 2015, Senegal's Minister for Health sent a request to the CCVS experts.

     

    Read more
  • Senegal

    Introduction of the Meningococcal A Conjugate Vaccine into routine immunization in Senegal: the NITAG is getting ready

    18.10.2016

    Requested by the Minister of Health to issue a recommendation on the introduction of the Meningococcal A Conjugate Vaccine into routine immunization, the Advisory Committee on Immunization in Senegal (CCVS) has established a working group to prepare a technical dossier to guide experts in their deliberations. The Working Group (WG) met in a workshop in Mbour from 12th to 14th October 2016.

    With technical support from SIVAC initiative of HPID Center, the working group finalized the recommendation framework which specify critical data to support Senegal NITAG opinion on the relevance of the introduction of the meningococcal A conjugate vaccine into routine childhood immunization in Senegal. The working group also identified relevant studies from which evidence will be collected. The quality of this evidence will be assessed and data synthesized and analysed to prepare a strong technical dossier which will later form a basis for experts to make an informed decision on the subject. 

    Read more
  • SAGE

    new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

    13.05.2019

    Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

    Read more